StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 7/30
$0.29−0.08 (-20.99%)

Close on Nov 20, 2026Market cap $12.23MP/E –Yield –

MIRA Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MIRA Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.64M. For fiscal 2025 it was -$4.66M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.66M–
FY2024Dec 31, 2024-$5.56M–
FY2023Dec 31, 2023-$4.53M–
FY2022Dec 31, 2022-$5.60M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.21M–
Q1 FY2026Mar 31, 2026-$1.20M–
Q4 FY2025Dec 31, 2025-$1.14M–
Q3 FY2025Sep 30, 2025-$1.10M–
Q2 FY2025Jun 30, 2025-$799.65K–
Q1 FY2025Mar 31, 2025-$1.63M–
Q4 FY2024Dec 31, 2024-$1.81M–
Q3 FY2024Sep 30, 2024-$1.84M–
Q2 FY2024Jun 30, 2024-$863.93K–
Q1 FY2024Mar 31, 2024-$1.05M–
Q4 FY2023Dec 31, 2023-$1.04M–
Q3 FY2023Sep 30, 2023-$1.76M–
Q2 FY2023Jun 30, 2023-$660.81K–
Q1 FY2023Mar 31, 2023-$1.08M–
Q4 FY2022Dec 31, 2022-$975.44K–
Q3 FY2022Sep 30, 2022-$1.31M–

More MIRA Pharmaceuticals figures

See a number that looks wrong?